Fingerprint
Dive into the research topics of 'Targeted and cytotoxic therapy in coordinated sequence (TACTICS): Erlotinib, bevacizumab, and standard chemotherapy for nonsmall-cell lung cancer, a phase II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically